本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Solid Biosciences

5.03
+0.16003.29%
盘后4.91-0.1195-2.38%16:54 EDT
成交量:70.23万
成交额:352.05万
市值:3.90亿
市盈率:-1.72
高:5.13
开:4.97
低:4.85
收:4.87
数据加载中...
2024/01/23

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/01/13

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/01/13

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/01/12

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/01/12

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/01/10

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/01/08

重要事件披露

Form 8-K - Current report
2023/11/15

重要事件披露

Form 8-K - Current report
2023/11/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/06/09

重要事件披露

Form 8-K - Current report
2023/06/06

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/05/23

重要事件披露

Form 8-K - Current report
2023/05/11

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/03/23

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/03/23

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2023/03/20

重要事件披露

8-K - Current report
2023/03/13

重要事件披露

8-K - Current report
2023/02/13

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/13

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals